TIM
BNTX icon

Total Investment Management’s BioNTech BNTX Stock Holding History

Total Investment Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1
Closed -$106 – 185
2025
Q2 		$106 Buy
+1
New +$101 ﹤0.01% 836

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Total Investment Management's BNTX Position: Q3 2025 in Review

Total Investment Management sold out of BioNTech (BNTX) in Q3 2025, closing a stake of 1 share — an estimated $106 sold.

Total Investment Management first reported a position in BNTX in Q2 2025 and held it in 1 quarter. The position peaked at $106 in Q2 2025. 254 funds tracked by Wall St. Rank hold BNTX as of Q3 2025.

  • Total Investment Management reported no remaining BioNTech position as of Q3 2025 after selling out during the quarter.
  • Total Investment Management sold 1 BioNTech share in Q3 2025, an estimated $106.
  • Total Investment Management first reported a position in BioNTech in Q2 2025 and held it in 1 quarter.
  • Total Investment Management's BioNTech position peaked at $106 in Q2 2025.
  • 254 funds tracked by Wall St. Rank held BioNTech as of Q3 2025.

Based on Total Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.